FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

172 letters match. Newest first.

  1. Jiangsu Hengrui Pharmaceuticals Co., Ltd.

    FDA found data integrity failures and inadequate sterile manufacturing controls at Jiangsu Hengrui Pharmaceuticals' drug facility.

    High risk
  2. Techlem Medical Corporation

    Techlem Medical Corporation failed quality and unique device identifier requirements for wheeled stretchers, FDA says.

    Medium
  3. Biomic Sciences, LLC dba ION Intelligence of Nature

    Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.

    High risk
  4. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk
  5. Central Admixture Pharmacy Services, Inc.

    FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.

    High risk
  6. Seatex, LLC

    Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.

    High risk
  7. FirstCham Co., Ltd.

    FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.

    High risk
  8. Deqing Jiarou Daily Chemical Co., Ltd.

    Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.

    High risk
  9. Thai Nakorn Patana Co., Ltd.

    FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.

    High risk
  10. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  11. Sichuan Deebio Pharmaceutical Co. Ltd.

    FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.

    High risk
  12. Curtis Jacquot dba Pacific BioLogic Co.

    Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.

    High risk
  13. S & J International Enterprises Public Company Limited

    FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.

    High risk
  14. Colonial Dames Company, Ltd

    FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.

    High risk
  15. AmLion Toothpaste Mfg. Sdn. Bhd.

    FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.

    High risk
  16. National Chemical Laboratories

    National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.

    High risk
  17. Natural Relief Inc.

    Natural Relief Inc. of Coshocton, Ohio, sold two herbal capsule products as unapproved drugs and had serious supplement manufacturing violations.

    High risk
  18. InnoMark, Inc.

    FDA warned InnoMark, Inc. about dietary supplements made under poor manufacturing conditions and with misleading labels after a March 2023 inspection.

    High risk
  19. Seoul Cosmetics Co., Ltd.

    FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.

    High risk
  20. PureChemPros LLC

    FDA warns PureChemPros over manufacturing quality failures and unapproved, misbranded hand sanitizer and hydrogen peroxide drugs.

    High risk
  21. Moorish Science Temple, The Divine and National Movement of North America, Inc; #13 The Moorish American National Republic dba Moor Herbs, Inc.

    FDA warned Moor Herbs that its herbal products are unapproved drugs with disease claims and are made without required supplement quality controls.

    High risk
  22. Osmosis, LLC

    Osmosis sold unapproved drug products with disease claims and had dietary supplement CGMP and labeling violations.

    High risk
  23. Reckitt/Mead Johnson Nutrition

    FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.

    High risk
  24. ByHeart, Inc.

    FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.

    High risk
  25. Perrigo Wisconsin, LLC

    FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.

    High risk
  26. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.

    High risk
  27. STPCA Inc. dba Sun Ten Laboratories

    FDA: Sun Ten Laboratories sold herbal products as unapproved drugs and broke supplement manufacturing rules at its Irvine, California plant.

    High risk
  28. LCC Ltd.

    LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.

    High risk
  29. Intas Pharmaceuticals Limited

    FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.

    High risk
  30. Medgel Private Limited

    FDA cited Medgel Private Limited, an Indian OTC drug maker, for manufacturing violations including poor investigations and data integrity failures.

    High risk
  31. Avlon Industries, Inc.

    FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.

    High risk
  32. Jamol Laboratories, Inc.

    FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.

    High risk
  33. Eden’s Answers, Inc.

    Eden’s Answers dietary supplements are adulterated by manufacturing-rule violations and misbranded by label omissions.

    Medium
  34. Brand Packaging Group, Inc.

    Brand Packaging Group, a Farmingdale, NY dietary supplement maker, failed to test finished batches and ingredient identity, FDA found.

    High risk
  35. Mr. Lulu LLC

    FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.

    High risk
  36. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  37. EarthLab, Inc., dba Wise Woman Herbals

    FDA warned EarthLab, doing business as Wise Woman Herbals, over unapproved drug claims and supplement CGMP violations.

    High risk
  38. Zermat International S.A. de C.V.

    FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.

    High risk
  39. Aspire Pharmaceuticals, Inc.

    FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.

    High risk
  40. Cosmetic Science Laboratories LLC

    FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.

    High risk
  41. Herbal Vitality, Inc.

    FDA says Herbal Vitality's herbal tinctures were unapproved drugs and misbranded supplements.

    High risk
  42. Olympus Medical Systems Corp.

    FDA warned Olympus Medical Systems about endoscope accessories for quality-system, complaint, packaging-seal, and reporting failures.

    High risk
  43. Midlab Incorporated

    FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.

    High risk
  44. Zing Brothers LLC

    FDA warns Zing Brothers LLC that its dietary supplements were made without required CGMP controls and have misleading labels.

    Medium
  45. Ultra Chem Labs Corporation

    FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.

    High risk
  46. American Chinese Natural Herbs, Inc.

    FDA warned Garland, Texas-based American Chinese Natural Herbs, Inc. about adulterated (legally unsafe) dietary supplements made without required manufacturing controls and with mislabeled products.

    High risk
  47. Clean Cosmetics LLC

    FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.

    High risk
  48. Quality Supplement Manufacturing, Inc.

    FDA cited Quality Supplement Manufacturing for dietary supplement manufacturing and labeling violations, including undeclared shellfish allergens.

    High risk
  49. Adept Life Science, LLC

    FDA found Adept Life Science, LLC made dietary supplements under poor manufacturing controls and with misbranded labels.

    Medium
  50. Kari Gran Inc.

    Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.

    High risk